Beneficiary Portugal 2020

PHYZAT BIOPHARMACEUTICALS, LDA

On this page

Beneficiary form

Name

PHYZAT BIOPHARMACEUTICALS, LDA

Financing value

702,5 thousand €

Total projects

Tax identification number

SIRNAC .: Nova Terapêutica de siRNA para o Cancro Colorectal Metastático

Financing value 338,82 thousand €

siRNAGlau .: Nova terapêutica de RNA de interferência para o Glaucoma.

Financing value 229,48 thousand €

SIRNACOVID .: Nova Terapia contra o SARS-CoV-2

Financing value 134,2 thousand €